Haupt Pharma is one of Europe's largest pharmaceutical contract manufacturers and developers, with 9 production sites and about 2,000 employees in Germany, France, Italy and Japan. Haupt Pharma provides tailor-made solutions for nearly all dosage forms and a variety of special products including cytotoxics, sexual hormones, thyroid hormones, narcotics and beta-lactams.
Clients benefit from a full service spanning pharmaceutical development, manufacturing of clinical trial supplies, regulatory services, commercial manufacturing, packaging and logistics.
The plant located in Regensburg focuses on solid dose hormones and cytotoxics but it also offers the manufacturing of conventional dosage forms (solids, semi-solids, liquids). In addition, development services and the production of clinical trial supplies are handled at this site.
Haupt Pharma Berlin was the starting point for Haupt Pharma and has remained of major significance.
Always eager to develop new ways of production and to improve existing production processes, this plant developed a special method of aqueous film-coating which meets the requirements for environmental protection.
Our plant in Berlin offers large capacity in the production of generic pharmaceuticals, dietary supplements and herbal medicines in solid dosage forms such as granules, tablets (film and sugar-coated), dry syrup and hard capsules.
The speciality of the Brackenheim site is blister packaging. This modern high-tech plant has an annual production capacity of 200 million blisters in finished packs. Pharmaceuticals are expertly packaged and distributed to the customers on time. More than 300 deep-draw format sets are at disposal to meet all individual requirements. The site also offers packaging and distribution of clinical trial supplies.
Haupt Pharma Development coordinates and carries out development projects for various dosage forms. The services include analytical and formulation development, process validation, pilot scale production and stability studies. Separated working areas allow the handling of toxic and other critical active substances.
The Italian site specialises in antibiotics, especially beta-lactams like penicillin and cephalosporin (aseptically filled powders and liquids preparations in vials, sterile suspensions in syringes, tablets and capsules in blisters and foils, non-sterile powders in bottles) and produces injectables and solid drugs for human and veterinarian use.
Haupt Pharma Livron is the largest producer of suppositories within the group. The site also specialises in the highly efficient production of sterile ampoules and hard capsules.
It offers a modern production facility and state-of-the-art equipment to the customers.
The production site in Münster specialises in the development and high-quality contract manufacturing of oral high-potent, low-dose products (contraceptives, thyroid hormones, narcotics) in entirely separate areas and offers competent packaging of solids in blisters and bottles. The site also offers the manufacturing of clinical trial supplies.
The Japanese production site in Toride manufactures sterile drugs in 1ml - 5ml ampoules. A special feature is the microwave sterilization. The site also provides inspection and packaging services.
The production plant in Wolfratshausen utilizes isolator technology for sterile products and a dedicated area for the manufacturing of cytotoxics. This site produces nearly all pharmaceutical forms including parenterals (ampoules / vials), semi-solids and solids. The manufacturing of clinical trial supplies is also offered at this site.
The site in Gronau produces solid, semisolid and sterile pharmaceutical forms. These include powders, granulates, tablets, film-coated tablets, sugar-coated tablets, capsules, ampoules (1-50ml), vials (1-20ml), powders filled in sterile containers, and suppositories. In addition the site offers development and packaging services as well as clinical trial supplies.
HAUPT Pharma AG
Pfaffenriederstr. 5-7
82515 Wolfratshausen
Germany
Tel: +49 (8171) 414 126
Fax: +49 (8171) 414 109
Email:
hans-wolfram.hardtke@haupt-pharma.de
URL:
www.haupt-pharma.com